• |
  • |
  • |
  • |
Donate

Project

Baby HUG Follow-up Study II: Clinical Sites

Center:
Fiscal Year:
2016
Contact Information:
Project Description:
This is a multi-center follow-up of infants and toddlers with sickle cell anemia who participated on a double-blind, randomized, placebo-controlled clinical trial of hydroxyurea. Neurodevelopment is one of the key endpoints.
Keyword(s):
sickle cell disease, central nervous system, hydroxyurea, neurodevelopment
Core Function(s):
Training Trainees, Performing Direct and/or Demonstration Services, Performing Research or Evaluation, Developing & Disseminating Information, Continuing Education/Community Training
Area of Emphasis
Health-Related Activities
Target Audience:
Professionals and Para-Professionals, Family Members/Caregivers, Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English
Primary Target Audience Geographic Descriptor:
Mulit-County
Funding Source:
Federal
COVID-19 Related Data:
N/A